NU643 2022 January Discussions Latest (Full)

NU643 Advance Psychopharmacology

Week 1 Discussion 

Prescriptive Practice in Psychiatric Nursing

Toward a New Understanding of Mental Illness (3:05 minutes)

Toward a New Understanding of Mental Illness Video Transcript

To complete this discussion

Compare the Ted Talk video to the NY Times article by Carlat, D. (2010). Mind Over Meds (PDF), and answer the following questions:

How do you view the role of psychiatric medication in the promotion of patient well-being?

What are the advantages and disadvantages of being a psychopharmacologist versus also integrating psychotherapy in your clinical practice?

What does the literature say (that is, support for or lack of evidence) for integration of psychotherapy and prescribing by the same clinician (APRN or MD)?

What evidence supports the use of both psychotherapy and psychopharmacology as the role for the PMHNP to improve patient outcomes?

Instructions

Carefully read the questions presented.

Reflect on the assigned materials from this week and consider experiences from your own practice to support your ideas. Please use proper citations and APA format.

You may wish to refer to outside sources as well to support your statements.

 

NU643 Advance Psychopharmacology

Week 2 Discussion 

Neurotransmitters

Initial Post

By now, you have chosen your neurotransmitter topic for this discussion forum.

Topic 1: Dopamine

Topic 2: Norepinephrine

Topic 3: Gaba-aminobutyric acid (GABA)

Topic 4: Serotonin

Topic 5: Glutamate

For this discussion, each student will create a four to five slide PowerPoint presentation including voice-over, that will be used to educate your fellow classmates on your chosen topic. Be creative in presenting your topic and include at least two references (in APA format) beyond Stahl for your information.

Each student is to create a PowerPoint for their topic and submit to this discussion forum when complete.

Please answer the following questions in your presentation.

What is the function of your neurotransmitter?

What is the pathway of origin and projections?

Is your neurotransmitter excitatory or inhibitory?

What behaviors are associated with this neurotransmitter?

 

NU643 Advance Psychopharmacology

Week 3 Discussion 

DQ1 Enzymes

Initial Post

By now, you have chosen your enzyme topic for this discussion forum.

Topic 1: CYP 1A2 enzyme

Topic 2: CYP 2D6 enzyme

Topic 3: CYP 3A4 enzyme

For this discussion, each student will create a four to five slide PowerPoint presentation including voice-over, that will be used to educate your fellow classmates on your chosen topic. Be creative in presenting your topic and include at least two references (in APA format) beyond Stahl for your information.

Each student is to create a PowerPoint for their topic and submit to this discussion forum when complete. Please answer the following questions in your presentation.

What is your enzyme?

Why is it important?

What does it do in the human body?

What are the common medications that inhibit the enzyme, including any substrates?

What are the important medication restrictions regarding this enzyme?

DQ2 Psychotropic Drugs

Overview

For this assignment, you will choose one psychotropic drug that is metabolized by CYP450 enzymes and complete the following steps:

Create a brief PowerPoint presentation, including voice-over, hypothesizing the outcome of prescribing your chosen drug in the presence of its CYP450 inhibitor and inducer.

Answer the following questions:

What are examples of drugs that will inhibit and induce the psychotropic drug you chose to study? What will happen, e.g., side effects, symptoms in the patient if the psychotropic drug was prescribed along with either its (1) inhibitor or (2) inducer?

For which CYP450 enzyme/s is it a substrate?

What are the pharmacokinetic considerations when prescribing this medication (absorption, distribution, elimination)? Dietary considerations? Dosing times

Initial Post

Once you have created your summary and presentation, submit under the appropriate discussion thread topic.

 

NU643 Advance Psychopharmacology

Week 6 Discussion 

Depression Scenarios

Initial Post

For this discussion you will build on your treatment plan from Week 5 Assignment 1: Depression Case Study. You will be seeing your patient at the six-week follow-up.

Describe your treatment plan for your patient in each of these three scenarios. This means that you will have a treatment plan for each separate scenario.

Your initial post should be in APA format with evidence-based references to support your statements.

Scenarios

There is no response to the medication.

There is a partial response to the medication. Mood has lifted but energy and motivation are still poor.

Mood is improved but the patient has sexual side effects that interfere with quality of life.

 

NU643 Advance Psychopharmacology

Week 9 Discussion 

Harold or Greg ADHD Case Study

Initial Post

You will need to use the following log-in information to access these videos (all case sensitive):

Video Login Site

Username: Nursing

Password: 0908

To access the site, choose the login button from the upper right corner of the screen.

Enter the login criteria.

View the following case study videos and choose one for your discussion post by clicking on the links (You must be logged in to access the video links):

Harold Case Study Video

Harold Case Study Video Transcript

Greg Case Study Video

Greg Case Study Video Transcript

Answer the following questions and post to this discussion forum:

What symptoms of ADHD does your patient present with?

What are other possible causes of his symptoms?

What further information, if any, would you like about this case?

With the assumption that the patient does have ADHD, what medication would you prescribe (list name and dose)? Why?

List any relevant safety information and screening (labs, etc) related to your medication choice.

Your initial post should be in APA format with evidence-based references to support your statements.

 

NU643 Advance Psychopharmacology

Week 10 Discussion 

DQ1 Opioid Use

Initial Post

View the Opioid Use Disorders Video | Opioid Use Disorder Moderate Transcript

You will need to use the following log-in information to access this video (all case sensitive):

Username: Nursing

Password: 0908

To locate the film, press CTRL + F to bring up a search area in the top right hand corner of the website. Enter F11.20 in the search box. You will see arrows in the search area to scroll through the options. You are looking for F11.20 Opioid Use Disorder; Moderate located under the DSM 5 heading and Substance-Related and Addictive Disorders subheading. Note: Please be sure to search for the heading (Substance Related Addictive Disorders) first and then the specific case study (F11.20) to ensure you locate the correct film.

Answer the following questions:

What symptoms of Substance Abuse Disorder does the individual in the video present with?

What are other possible causes of his symptoms?

What additional information would you like to have about this case?

Would you prescribe for this individual? Why or why not?

What would your next steps be for this individual? What would your treatment plan be?

Your initial post should be in APA format with evidence-based references to support your statements.

DQ2 Groups Work on Pediatric Clinical Reference Tool

Overview

For this discussion, you will work in a group of two to three students to create a Pediatric Clinical Reference Tool for a disorder to be used in clinical practice and that can be shared with your peers. Please note, this discussion is not graded and is used as your tool of communication with your group.

Each student will be randomly assigned to a group that is associated with a topic. Here is a list of the topics and their associated groups:

Topic 1: Generalized Anxiety (Group 1)

Topic 2: Depression (Group 2)

Topic 3: Bipolar Disorder (Group 3)

Topic 4: Autism Spectrum Disorder (Group 4)

Topic 5: Obsessive Compulsive Disorder (Group 5)

Topic 6: Schizophrenia/Psychotic Disorders (Group 6)

Topic 7: Aggression (Group 7)

Topic 8: Addiction (Group 8)

Once you are placed in the groups, you can use this discussion forum to determine which method you will use to communicate within your groups. You may use Zoom, email, phone, or any other agreed upon method.

Within your group, complete the Pediatric Clinical Template (PDF) to answer the following questions:

How does the topic present in children and, if applicable, how does that presentation differ in adults?

What are the treatment recommendations for children? Adolescents? (Use available resources including but not limited to linked treatment guidelines, The Carlat Child Psychiatry Report, UptoDate, etc..

Which treatment recommendations are off-label? FDA approved?

What are the relevant safety issues? (This may include risks associated with the topic or with the treatment.) Do these safety issues differ from adults?

Your response should include evidence of review of the course material through proper citations using APA format.

Check with the Pediatric Grading Rubric for evaluating your Pediatric Clinical Template.

When the group assignment is complete, select one group member to upload it to the Week 11 Discussion 1: Pediatric Clinical Reference Tool for your peer discussion. Please ensure that all group members are listed on the Pediatric Treatment Reference assignment so that everyone in the group will receive a grade for the submission.

Note: You will also need to individually submit the Pediatric Clinical Template (PDF) in Week 11 Assignment: Pediatric Treatment Reference.

 

NU643 Advance Psychopharmacology

Week 11 Discussion 

Pediatric Clinical Reference Tool

Initial Post

Choose one group member to upload the Pediatric Clinical Reference Tool for your group to this discussion forum. Please ensure that all group members are listed on the Pediatric Treatment Reference assignment so that everyone in the group will receive a grade for the submission.

 

NU643 Advance Psychopharmacology

Week 13 Discussion 

DQ1 Pregnancy and Lactation Research

Initial Post

Note: Consider your prior case studies for Depression in Module 5 and Bipolar Disorder in Module 7. Revisit and thoroughly review them.

How would your treatment plan (medications, therapy, etc) change for the pregnant female in Module 5 with Depression and Module 7 with Bipolar Disorder?

How would this change if the female were lactating (breastfeeding)?

What patient teaching would you include?

Please use proper citations and APA format.

DQ2 Choosing the Non-Herbal Topic for the Complementary Treatment Discussion

Initial Post

Identify a non-herbal complementary treatment with purported mental health benefits. Examples include but are not limited to: light boxes, fidget toys, aromatherapy, yoga, meditation, Tai Chi, Qigong, breath exercises, massage, mental health apps, laughter yoga, acupuncture, aerobic exercise, guided imagery, mandalas, labyrinths, foot care, Himalayan salt lamps, etc. You are encouraged to choose a topic of interest to you.

Important!

Only one complementary treatment is to be chosen per student. Before you begin to answer the questions posted in the Week 14 discussion forum, review this discussion board to determine which treatments have already been chosen.

Your initial post is to let your peers know what complementary treatment you are choosing so no one else chooses the same treatment. When you have posted your complementary treatment choice to this discussion board, move on to the Week 14 Discussion 1: Complementary Treatment discussion and complete. Where appropriate, please use proper citations and APA format.

 

NU643 Advance Psychopharmacology

Week 14 Discussion 

Complementary Treatment

Initial Posts

At this point: You should have chosen and posted your non-herbal complementary treatment topic.

For this discussion will complete the following in a one-page summary:

Describe the complementary treatment.

What is it?

What are its proposed benefits?

Are there any risks?

Describe access to the treatment - where do you find it, what are its costs?

Is there evidence for your treatment? Expert opinion? If so, what is it?

Based on your findings would you recommend this treatment? If yes, do you have population-specific recommendations?

Use proper citations with APA format.